Register and share your invite link to earn from video plays and referrals.

Search results for EliLilly
EliLilly community
One keyword maps to one global community path.
Create community
People
Not Found
Tweets including EliLilly
Now on Ro: Foundayo from @EliLillyandCo—the newest GLP-1 pill. This treatment offers patients a flexible, daily pill option that’s delivered directly to their door, at the best cash price.
Show more
Hear @LinaPolimeni, CMO for Consumer at @EliLillyandCo $LLY, share her perspective on the impact and importance of the @Forbes 2026 World’s Most Influential CMO List ⤵️
Everyone’s chasing $NVDA. @commonsensebull says investors should be looking at AI winners like $LLY, too. #Nvidia# #EliLilly#
💡 One AI factory. 1,016 NVIDIA Blackwell Ultra GPUs. Over 9,000 petaFLOPs of AI performance. @EliLillyandCo and NVIDIA launch LillyPod, the world's first #NVIDIADGX# SuperPOD with DGX B300 systems to accelerate drug discovery, medical research, operational efficiency, and enhance industry collaboration. Together, by combining science, data, and compute power, we're breaking new ground for AI in life sciences. Learn how we're advancing the broader biotech ecosystem. ➡️
Show more
Eli Lilly becomes first drugmaker to have a GLP-1 weight-loss pill approved in China
ELI LILLY SHARES GAIN 3% AS CHINA APPROVES ORAL GLP-1 DRUG.
ELI LILLY SHARES UP 2% PREMARKET AFTER CO BECOMES THE FIRST DRUGMAKER TO HAVE GLP-1 WEIGHT LOSS PILL APPROVED IN CHINA.
Eli Lilly becomes first drugmaker to have a GLP-1 weight loss pill approved in China
ELI LILLY'S TALTZ+ZEPBOUND HIT PRIMARY ENDPOINT AT WEEK 36
Eli Lilly & Co.’s weight loss pill Foundayo helped control sleep apnea in two large trials, reducing nighttime disruptions for patients and paving the way for a new use for the daily drug.
Show more